OCT 10, 2018 1:30 PM PDT

Discovery of Biomarkers Predictive of Anticancer Drug Response in Preclinical Settings

Speaker

Abstract

One of the main challenges in precision medicine consists of developing predictors of drug response to select the most beneficial therapy for each individual patient. In this context, preclinical models are crucial to study the association between molecular features of tumor cells and response to chemical perturbations. However, only few predictors have been successfully translated to clinical settings. Such a low success rate is due not only to the complexity of the mechanisms underlying anticancer drug response, but also to the lack of robustness of the predictors developed in preclinical settings. To address this issue we developed PharmacoGx, a computational platform enabling meta-analysis of large-scale drug screenings of in vitro and in vivo model systems, and PharmacoDB (pharmacodb.pmgenomics.ca), a web-application enabling quick access to a large compendium of pharmacogenomics datasets. In this presentation I will show how we used our new platforms to (i) identify pathways whose genomic and transcriptomic patterns are preserved between model systems and patient tumors, and (ii) develop univariate and multivariate predictors of drug response that can be validated in clinical trial data. 

Learning Objectives: 

1. Learn about the potential and limitations of biomarker discovery using preclinical pharmacogenomic data
2. Learn about the computational tools available for biomarker discovery in preclinical settings


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
OCT 10, 2018 1:30 PM PDT

Discovery of Biomarkers Predictive of Anticancer Drug Response in Preclinical Settings


Specialty

Cancer

Cell Culture

Biotechnology

Antibodies

Immunology

Bioinformatics

Cancer Research

Biomarkers

Oncology

Gene Sequencing

Drug Discovery

Personalized Medicine

Immunity

Immunotherapy

Biobank

Geography

North America25%

Asia25%

Europe25%

Oceania25%

Registration Source

Website Visitors100%

Job Title

Student50%

Biologist25%

Research Scientist25%

Organization

Academic Institution75%

Contract Research Organization (Cro)25%


Show Resources
Loading Comments...
Show Resources